For every ten cancer patients treated, an average of only half will benefit. For some, the treatment won’t have any effect; others may suffer from serious side effects.1 Ventana Medical Systems, Inc. A Member of the Roche Group is working at our industry’s forefront to change this dynamic by customizing therapy to individual patients, helping you to improve diagnostic accuracy, lab efficiency and patient safety.
In collaboration with leading pharmaceutical companies, we identify and develop innovative companion diagnostics to target those patients who are likely to respond to specific therapies. Because we recognize the tremendous potential for these solutions, we continue to focus on addressing unmet medical needs by developing the cutting-edge tools you need.
You can be confident that VENTANA products, from Roche, are the right solution to empower you to deliver the high-quality diagnostic information for patients — today and in the future.
One of the global leaders in tissue-based cancer diagnostics, we provide a premier end-to-end offering, with expertise at every stage from discovery to commercialization. Working together under one roof, Roche and pharma increase the efficiency and speed of developing patient selection biomarkers.
Helping to deliver the promise of Personalized Healthcare
1 Source: Roche Personalized Healthcare brochure, 2011.